Patiroglu Turkan, et al.
Phytomedicine, 2012
Abstract
Transient hypogammaglobulinemia of infancy (THI), defined as prolongation of physiological hypogammaglobulinemia normally seen between the initial 3rd and 6th months of life, is one of the most common immune deficiencies of childhood. Recurrent upper respiratory tract infections (URTI) are rather common in this group of patients, and generally, antibiotic treatment is the usual choice, although viruses involved in most cases. Pelargonium sidoides extract a herbal drug with known immunmodulator, antiviral and antibacterial effects. In this randomized, placebo controlled, prospective, monocentric pilot study, 14 of 28 patients with a diagnosed THI, were given Pelargonium sidoides, while 14 were given placebo during the period of URTI. Before and after the treatment period of one week, complete blood count, prothrombin time, activated prothromboplastin time, serum alanine aminotransferase, aspartate aminotransferase, gamma glutamyl transpeptidase, total and direct bilirubin levels were measured. Mothers were asked to fill in a questionnaire for the recovery of the clinical symptoms during the treatment. The results were evaluated and compared in both group to assess the effect of Pelargonium sidoides. As a conclusion, the Pelargonium sidoides group showed increased appetite. The Pelargonium sidoides were found to beneficial for the nasal congestion, recovery of daily and nocturnal cough but not found be significant. Further studies with large number of participants are necessary to highlight the effect of Pelargonium sidoides in children with transient hypogammaglobulinemia of infancy.
Copyright © 2012 Elsevier GmbH. All rights reserved.
| PMID: | 22809962 |
|---|---|
| DOI: | 10.1016/j.phymed.2012.06.004 |
| Category: | Cold / Flu |
Articles similar to "The Efficacy of Pelargonium Sidoides in the Treatment of Upper Respiratory Tract Infections in Children With Transient Hypogammaglobulinemia of Infancy."
- The significance of Pelargonium Sidoides for Cold / Flu: Efficacy of Proanthocyanidins From Pelargonium sidoides Root Extract in Reducing P. gingivalis Viability While Preserving Oral Commensal S. salivarius. (Bacterial resistance to antibiotics and the disruption of beneficial microbiota are key problems in contemporary medicine and make the search for new, more efficient infection treatment strategies among the most important tasks in medicine...)
- The role of Pelargonium Sidoides in Cold / Flu: Investigation of Antibacterial and Antiinflammatory Activities of Proanthocyanidins From Pelargonium sidoides DC Root Extract. (The study explores antibacterial, antiinflammatory and cytoprotective capacity of Pelargonium sidoides DC root extract (PSRE) and proanthocyanidin fraction from PSRE (PACN) under conditions characteristic for periodontal disease...)
- The impact of Pelargonium Sidoides on Cold / Flu: The Pelargonium Sidoides Extract EPs 7630 Drives the Innate Immune Defense by Activating Selected MAP Kinase Pathways in Human Monocytes. (Pelargonium sidoides is a medical herb and respective extracts are used very frequently for the treatment of respiratory tract infections...)
- The role of Pelargonium Sidoides in Cold / Flu: Efficacy of a Pelargonium Sidoides Preparation in Patients With the Common Cold: A Randomized, Double Blind, Placebo-Controlled Clinical Trial. ( The common cold is a viral infection with symptoms such as sneezing, sore throat, and running nose... EPs represents an effective treatment of the common cold. It significantly reduces the severity of symptoms and shortens the duration of the common cold compared with placebo. The herbal drug is well tolerated.)
- The impact of Pelargonium Sidoides on Cold / Flu: Efficacy and Tolerability of EPs 7630 Tablets in Patients With Acute Bronchitis: A Randomised, Double-Blind, Placebo-Controlled Dose-Finding Study With a Herbal Drug Preparation From Pelargonium Sidoides. (Objective: Acute bronchitis is one of the most frequent health complaints for which patients seek medical advice... This study demonstrated statistically significant and clinically relevant superiority of all three tested dosages of EPs 7630 over placebo. All dosages of EPs 7630 were well-tolerated. Taking into account both efficacy and safety, the results of this study indicate that the 20 mg tablets of EPs 7630 taken three times daily constitute the optimal dose with respect to the benefit-risk ratio.)
- The significance of Pelargonium Sidoides for Cold / Flu: Treatment of Acute Bronchitis in Adults With a Pelargonium Sidoides Preparation (EPs® 7630): A Randomized, Double-Blind, Placebo-Controlled Trial. ( Acute bronchitis is a widespread medical problem, and, although predominantly caused by viruses, antibiotics are still prescribed unnecessarily... EPs 7630 was superior in efficacy compared with placebo in the treatment of adults with acute bronchitis. It may therefore offer an effective alternative for acute bronchitis unless antibiotics are clearly indicated.)